EX-FILING FEES 10 ex_776337.htm EXHIBIT FILING FEES ex_776337.htm

Exhibit 107

Calculation of Filing Fee Tables

FORM S-1
(Form Type)

 

Moleculin Biotech, Inc.

(Exact Name of Registrant as Specified in its Charter) 

 

Table 1: Newly Registered Securities

 

 

Security

Type

Security Class Title

Fee
Calculation

or Carry
Forward

Rule

Amount

Registered

Proposed

Maximum

Offering

Price

Per Unit

Maximum
Aggregate
Offering Price(1)

Fee Rate

Amount of Registration Fee(1)

Newly Registered Securities

           

Fees to Be Paid

Equity

Common Stock, $0.001 par value per share(2)

457(o)

   

$20,000,000(4)

0.00015310

$ 3,062.00

Fees to Be Paid

Equity

Series C Warrants to purchase common stock(3)

457(g)

         

Fees to Be Paid

Equity

Series D Warrants to purchase common stock(3)

457(g)

         

Fees to Be Paid

Equity

Pre-Funded Warrants to purchase common stock(3)

457(g)

         
                 

Fees to Be Paid

Equity

Common Stock issuable upon exercise of Series C Warrants(2)

457(o)

   

$20,000,000(1)

0.00015310

$ 3,062.00

Fees to Be Paid

Equity

Common Stock issuable upon exercise of Series D Warrants(2)

457(o)

   

$20,000,000(1)

0.00015310

$ 3,062.00

Fees to Be Paid

Equity

Common Stock issuable upon exercise of Pre-Funded Warrants(2)

457(o)

         
                 

Carry Forward Securities

             

Carry

Forward

Securities

               
 

Total Offering Amounts

   

$60,000,000                                                                                        $9,186

 

Total Fees Previously Paid

   

$3,750.95

 

Total Fee Offsets

   

$0

 

Net Fee Due

   

$5,435.05

 

(1)

Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act.

 

(2)

Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder include such indeterminate number of additional shares of common stock as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions.

 

(3)

Pursuant to Rule 457(g) of the Securities Act, no separate registration fee is required for the warrants because the warrants are being registered in the same registration statement as the common stock issuable upon exercise of the warrants.

 

(4)

The proposed maximum aggregate offering price of the common stock proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants sold in the offering, and, as such, the proposed maximum aggregate offering price of the common stock and Pre-Funded Warrants (including the common stock issuable upon exercise of the Pre-Funded Warrants), if any, is $20,000,000.